Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies.

Efficient Enrichment of Retinal DHA with Dietary Lysophosphatidylcholine-DHA: Potential Application for Retinopathies.
复制标题

利用膳食溶血磷脂酰胆碱-DHA 高效富集视网膜 DHA:视网膜病变的潜在应用。

DOI:
10.3390/nu12103114
复制
发表时间:
2020-10-12
期刊:
影响因子:
5.9
通讯作者:
Subbaiah PV
Subbaiah PV
中科院分区:
医学2区
文献类型:
--
作者:
Sugasini D;Yalagala PCR;Subbaiah PV

文献摘要

参考文献

相似文献

虽然视网膜二十二碳六烯酸(DHA)减少是视网膜病的已知风险因素,但目前可用的ω-3脂肪酸补充剂(其作为三酰甘油(TAG)吸收)并不显著富集视网膜DHA。我们测试了这样的假设,即溶血磷脂酰胆碱(LPC)-DHA作为磷脂被吸收,将有效地增加视网膜DHA,因为在血液视网膜屏障的LPC特异性转运蛋白的存在。在正常大鼠中,LPC-DHA和在消化过程中产生LPC-DHA的二-DHA磷脂酰胆碱(PC)分别使视网膜DHA增加101%和45%,但在相同剂量(40 mg/kg,30天)下,TAG-DHA没有显著影响。在正常小鼠中,sn-1 DHA LPC和sn-2 DHA LPC均使视网膜DHA增加80%,但游离DHA没有影响。脂肪酶处理的磷虾油(含有LPC-DHA和LPC-EPA(二十碳五烯酸),但不含正常磷虾油(LPC很少),增加了视网膜DHA(+76%)和EPA(100倍)。然而,无论是否经过脂肪酶处理,鱼油都没有效果。这些研究表明,膳食LPC-DHA可以有效地增加视网膜DHA,但TAG-DHA或游离DHA不能。由于已知DHA可预防视网膜病变和其他眼部疾病,因此这项研究为预防/治疗这些疾病提供了一种新的营养方法。
Although decreased retinal docosahexaenoic acid (DHA) is a known risk factor for retinopathy, currently available omega-3 fatty acid supplements, which are absorbed as triacylglycerol (TAG), do not significantly enrich retinal DHA. We tested the hypothesis that lysophospahtidylcholine (LPC)-DHA which is absorbed as phospholipid, would efficiently increase retinal DHA because of the presence of LPC-specific transporter at the blood–retina barrier. In normal rats, LPC-DHA and di-DHA phosphatidylcholine (PC), which generates LPC-DHA during digestion, increased retinal DHA by 101% and 45%, respectively, but TAG-DHA had no significant effect at the same dose (40 mg/kg, 30 days). In normal mice, both sn-1 DHA LPC and sn-2 DHA LPC increased retinal DHA by 80%, but free DHA had no effect. Lipase-treated krill oil (which contains LPC-DHA and LPC-EPA (eicosapentaenoic acid), but not normal krill oil (which has little LPC), increased both retinal DHA (+76%) and EPA (100-fold). Fish oil, however, had no effect, whether lipase-treated or not. These studies show that retinal DHA can be efficiently increased by dietary LPC-DHA, but not by TAG-DHA or free DHA. Since DHA is known to be protective against retinopathy and other eye diseases, this study provides a novel nutraceutical approach for the prevention/treatment of these diseases.
DOI: 10.1016/j.mam.2018.09.003
发表时间: 2018-12
影响因子: 10.6
作者:
Bazan NG
通讯作者: Bazan NG
DOI: 10.1038/nature13241
发表时间: 2014-05-22
期刊: NATURE
影响因子: 64.8
作者:
Nguyen, Long N.;Ma, Dongliang;Silver, David L.
通讯作者: Silver, David L.
DOI: 10.1017/s0007114509991334
发表时间: 2010-01-14
影响因子: 3.6
作者:
Kaur, Gunveen;Begg, Denovan P.;Sinclair, Andrew J.
通讯作者: Sinclair, Andrew J.
DOI: 10.1017/s0007114512001419
发表时间: 2013-02-14
影响因子: 3.6
作者:
Kaur, Gunveen;Molero, Juan C.;Sinclair, Andrew J.
通讯作者: Sinclair, Andrew J.
DOI: 10.1007/s12035-015-9228-9
发表时间: 2016-07-01
影响因子: 5.1
作者:
Hachem, Mayssa;Geloen, Alain;Bernoud-Hubac, Nathalie
通讯作者: Bernoud-Hubac, Nathalie